the efficacy of the mint nasal spray 1.5% in treatment of nasal polyp.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20160821029460N2

Enrollment

Registered

2018-02-13

Start date

2016-08-22

Completion date

Unknown

Last updated

2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nasal polyp. Other polyp of sinus. Polyp of sinus: accessory ,ethmoidal ,maxillary ,sphenoidal

Interventions

Intervention 1: Intervention group: mint nasal spray 1.5% 2 puffs every 12 hours in each nostril and tablet cetirizine 10 mg daily for 4 weeks . Intervention 2: Control group: Nasal spray of placebo

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: patients aged 18 to 65 years old. having one of this symptoms: nasal obstruction, post nasal discharge, loss of smell, facial pain/pressure, runny nose, need to blow nose Diagnosis of nasal polyps with rhinoscopic examination and endoscopy

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
The size of the nasal polyp. Timepoint: before the intervention, 2 weeks after the intervention and immediately after it. Method of measurement: rhinoscopic examination and endoscopy.;Evaluation of quality of life and severity of symptoms. Timepoint: before the intervention, 2 weeks after the intervention and immediately after it. Method of measurement: standard snot-22 questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBahareh Parvin

Sari University of Medical Sciences

bparvin@mazums.ac.ir+98 11 3324 4893

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026